Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 4:04 PM
Ignite Modification Date:
2025-12-26 @ 4:04 PM
NCT ID:
NCT04641806
Eligibility Criteria:
Inclusion Criteria:
* adults aged at least 18 years
* Covid-19 confirmed by PCR
* between February and May 2020
* affiliated with a social security
* consenting to the study
Case specific inclusion criteria :
* being or having been affected by B-NHL
* being currently in remission, active surveillance or during first-line or second-line treatment
Exclusion Criteria:
* Subjects less than 18 years old
* Subject with protective measure (curatorship, guardianship, safeguard of justice) -Subjects unable to give consent
* Pregnant or breastfeeding women
* Subject refusing to participate
* Case-specific non-inclusion criteria :
* Patient with a life expectancy linked to NHLof less than 6 months or with a History of hematopoietic allogeneic stem cell transplant
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04641806
Study Brief:
Protocol Section:
NCT04641806